Science news articles about 'michael karin'

... transmembrane receptor signaling, these results may identify a potential therapy for interfering with inflammation," said Michael Karin, Ph.D., professor of pharmacology and pathology in UC San Diego' ...

... activity of the immunosuppressive drug rapamycin, recently found to have anti-cancer activity. The discovery by Michael Karin, Ph.D., professor of pharmacology in the Laboratory of Gene Regulation ...

... lethal form of cancer. The scientists – headed by Michael Karin, Ph.D., UC San ... spurs the growth and spread of metastatic cancer," said Karin. "If we can find a way to block the production of versican ...

... to ultimately benefit the treatment of cancer patients." Incidentally, the group of Professor Michael Karin from the University of California at San Diego, has reached similar conclusions in paper ...

Recent research from the laboratory of Michael Karin, PhD, at the University of California, San Diego School of Medicine – the first researcher to demonstrate a molecular link between inflammation and ...

... author Wei Tan, PhD, a postdoctoral fellow in the Department of Pharmacology at the UC San Diego School of Medicine and Michael Karin, PhD, professor of pharmacology in UCSD's Laboratory of ...

... as a stress." The JNK group of protein kinases – discovered in the lab of principal investigator Michael Karin in 1993 – responds to the stress of hypoxia by inducing the over-production of vascular ...